All In MedTech

FDA Clearance Tracker · K232524

Millipede 070 Aspiration Catheter; Perfuze Aspiration Tube Set

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Oct 18, 2023 (this decision)Source: openFDAMethods & limitations

510(k)Breakthrough

Decided

Oct 18, 2023

Substantially Equivalent

Time to decision

61 days

Received Aug 18, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K232524
Device name
Millipede 070 Aspiration Catheter; Perfuze Aspiration Tube Set
Applicant
Perfuze, Ltd.
Applicant location
Galway, IE
Received
Aug 18, 2023
Decided
Oct 18, 2023
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 870.1250
Specialty
Cardiology

Every decision under product code NRY

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NRY. The earliest in FDA's data is K033736, decided Aug 11, 2004.
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Perfuze, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.